DOGE claims $30M savings from canceling 30 FDA leases
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesGovernment/legislationMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)